Xcell Therapeutics Inc.

KOSDAQ:A373110 Stock Report

Market Cap: ₩61.6b

Xcell Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of A373110?
Owner TypeNumber of SharesOwnership Percentage
Institutions9,2180.0844%
Public Companies210,5261.93%
VC/PE Firms604,0805.53%
Private Companies1,259,24211.5%
Individual Insiders1,989,56418.2%
General Public6,845,83262.7%

Dilution of Shares: A373110 only recently listed within the past 12 months


Top Shareholders

Top 9 shareholders own 37.3% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.8%
Ui-Il Lee
1,719,564₩9.7b0%no data
5.53%
Korea Investment Partners Co. Ltd.
604,080₩3.4b0%2.53%
4.44%
APRJD Biomaterial New Technology Association No. 1
485,182₩2.7b0%no data
3.23%
Ignite Innovators Co., Ltd.
352,267₩2.0b0%no data
2.63%
Jw Asset Co., Ltd.
287,041₩1.6b0%no data
2.47%
Hyun-Jung Jung
270,000₩1.5b0%no data
1.93%
Daesang Corporation
210,526₩1.2b0%no data
1.23%
W Bio Co., Ltd.
134,752₩760.0m0%no data
0.084%
HDC Asset Management Co., Ltd.
9,218₩52.0m0%0.12%